跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEA
首页
药物
BEA
BEA
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Tin-containing zeolitic material having a BEA framework structure
US 9999878 B2
申请人: BASF SE
优先权: 2013
CN
EP
US
WO
5 件公开
US 10766781 B2
申请人: BASF SE
优先权: 2015
CN
EP
US
3 件公开
Catalyst comprising a mixture of an AFX-structure zeolite and a BEA-structure zeolite and at least one transition metal for selective reduction of NOx
US 11691134 B2
申请人: IFP ENERGIES NOW
优先权: 2018
CN
EP
US
WO
5 件公开
Protein refolding column filler and column
US 8394933 B2
申请人: KAWAKAMI MASAYUKI
优先权: 2007
EP
US
WO
4 件公开
Process for producing of epoxy compound
US 7994349 B2
申请人: SUMITOMO CHEMICAL CO
优先权: 2006
CN
US
3 件公开
Carbazole compounds and use of such compounds in organic electroluminiscent devices
US 2006073357 A1
申请人: BRUNNER KLEMENS
优先权: 2003
US
WO
2 件公开
pH-dependent gradual release pharmaceutical composition
US 9839607 B2
申请人: HAJNAL PÉTER
优先权: 2010
US
2 件公开
Chelated PSMA inhibitors
US 9446157 B2
申请人: BERKMAN CLIFFORD
优先权: 2012
US
2 件公开
Tellurium-containing molecular sieves
US 6329537 B1
申请人: ARCO CHEM TECH
优先权: 2000
US
Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
US 2002131938 A1
申请人: FARKAS BEA
优先权: 2001
US
Use of glycine in preparing composition for regulating weight and size of animals
CN 101090717 B
申请人: ORAGENICS INC
优先权: 2005
CN
第 1 / 3 页
上一页
下一页
药物
反馈